EX-99.3 5 g84217exv99w3.htm EX-99.3 SECOND QUARTER FINANCIAL TABLES EX-99.3 SECOND QUARTER FINANCIAL TABLES
 

EXHIBIT 99.3

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

                                   
      Three Months Ended   Six Months Ended
      June 30,   June 30,
     
 
      2003   2002   2003   2002
     
 
 
 
Revenue
  $ 246,471     $ 227,644     $ 481,214     $ 453,517  
Costs and expenses:
                               
 
Cost of operations
    143,582       135,648       277,962       274,179  
 
Development and engineering
    10,490       11,113       21,502       21,981  
 
Sales, marketing, general and administrative
    71,724       76,511       141,794       155,877  
 
Depreciation and amortization
    16,016       33,033       43,992       65,792  
 
Impairment of long-lived assets
    33,113       609       33,113       609  
 
Restructuring and integration charge (benefit)
          1,160             (2,590 )
 
Other income
    1,118       5,866       1,301       5,866  
 
Interest income
    4,994       6,022       10,049       9,162  
 
Interest expense
    2,927       2,954       5,848       3,095  
 
   
     
     
     
 
Loss before income tax provision
    (25,269 )     (21,496 )     (31,647 )     (50,398 )
 
Income tax provision
    1,001       713       1,981       1,413  
 
   
     
     
     
 
Net loss
  $ (26,270 )   $ (22,209 )   $ (33,628 )   $ (51,811 )
 
   
     
     
     
 
Basic and diluted net loss per common share
  $ (0.09 )   $ (0.07 )   $ (0.11 )   $ (0.17 )
 
   
     
     
     
 
Weighted-average shares outstanding used in computing basic and diluted net loss per common share
    304,001       309,462       303,447       310,565  
 
   
     
     
     
 

 


 

WebMD CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

                                   
      Three Months Ended   Six Months Ended
      June 30,   June 30,
     
 
      2003   2002   2003   2002
     
 
 
 
Revenues
                               
 
Transaction services
  $ 118,021     $ 117,204     $ 233,514     $ 235,131  
 
Physician services
    76,797       66,068       148,808       132,157  
 
Portal services
    26,538       18,006       48,718       35,140  
 
Plastic technologies
    31,649       31,509       62,187       61,050  
 
Inter-segment eliminations
    (6,534 )     (5,143 )     (12,013 )     (9,961 )
 
   
     
     
     
 
 
  $ 246,471     $ 227,644     $ 481,214     $ 453,517  
 
   
     
     
     
 
Income (loss) before taxes, restructuring, non-cash and other items
                               
 
Transaction services
  $ 22,342     $ 18,264     $ 46,393     $ 35,802  
 
Physician services
    6,359       6,234       12,656       12,486  
 
Portal services
    6,192       (2,219 )     10,210       (7,056 )
 
Plastic technologies
    7,967       8,197       15,247       15,795  
 
Corporate
    (12,381 )     (12,641 )     (24,843 )     (27,248 )
 
Interest income
    4,994       6,022       10,049       9,162  
 
Interest expense
    (2,927 )     (2,954 )     (5,848 )     (3,095 )
 
   
     
     
     
 
 
  $ 32,546     $ 20,903     $ 63,864     $ 35,846  
 
   
     
     
     
 
 
Basic and diluted income per common share before taxes, restructuring, non-cash and other items (a)
  $ 0.11     $ 0.07     $ 0.21     $ 0.12  
 
   
     
     
     
 
Taxes, restructuring, non-cash and other items (b)
                               
 
Depreciation and amortization
  $ (16,016 )   $ (33,033 )   $ (43,992 )   $ (65,792 )
 
Amortization of prepaid content and services (included in cost of operations)
    (827 )     (750 )     (827 )     (1,724 )
 
Amortization of prepaid content and services (included in sales, marketing, general and administrative)
    (5,176 )     (5,399 )     (11,322 )     (11,685 )
 
Non-cash stock compensation (included in sales, marketing, general and administrative)
    (3,801 )     (7,314 )     (7,558 )     (14,890 )
 
Impairment of long-lived assets
    (33,113 )     (609 )     (33,113 )     (609 )
 
Restructuring and integration (charge) benefit
          (1,160 )           2,590  
 
Income tax provision
    (1,001 )     (713 )     (1,981 )     (1,413 )
 
Other income
    1,118       5,866       1,301       5,866  
 
   
     
     
     
 
Net loss
  $ (26,270 )   $ (22,209 )   $ (33,628 )   $ (51,811 )
 
   
     
     
     
 
 
Basic and diluted net loss per common share
  $ (0.09 )   $ (0.07 )   $ (0.11 )   $ (0.17 )
 
   
     
     
     
 
 
Weighted-average shares outstanding used in computing basic and diluted net loss per common share
    304,001       309,462       303,447       310,565  
 
   
     
     
     
 


(a)   Basic and diluted income per common share before taxes, restructuring, non-cash and other items is based on the weighted average shares outstanding used in computing basic and diluted net loss per common share.
 
(b)   Reconciliation of income before taxes, restructuring, non-cash and other items to net loss.

 


 

WebMD CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

                     
        June 30,   December 31,
        2003   2002
       
 
        (Unaudited)
Assets
               
Cash and cash equivalents
  $ 461,530     $ 179,541  
Short-term investments
    216,060       10,888  
Accounts receivable, net
    178,357       170,467  
Inventory
    19,724       18,804  
Current portion of prepaid content and distribution services
    24,944       25,406  
Other current assets
    21,180       26,197  
 
   
     
 
   
Total current assets
    921,795       431,303  
Marketable debt securities
    268,222       449,289  
Marketable equity securities
    7,504       7,427  
Property and equipment, net
    89,160       94,737  
Prepaid content and distribution services
    37,290       48,532  
Goodwill
    615,488       629,055  
Intangible assets, net
    50,051       79,536  
Other assets
    35,801       26,369  
 
   
     
 
 
  $ 2,025,311     $ 1,766,248  
 
   
     
 
Liabilities and Stockholders’ Equity
               
Accounts payable
  $ 13,880     $ 11,494  
Accrued expenses
    186,280       212,600  
Deferred revenue
    86,588       81,179  
Current portion of long-term debt
          6,546  
 
   
     
 
 
Total current liabilities
    286,748       311,819  
Convertible subordinated notes
    599,999       300,000  
Other long-term liabilities
    631       628  
Stockholders’ equity
    1,137,933       1,153,801  
 
   
     
 
 
  $ 2,025,311     $ 1,766,248  
 
   
     
 

 


 

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

                       
          Six Months Ended
          June 30,
         
          2003   2002
         
 
Cash flows from operating activities:
               
Net loss
  $ (33,628 )   $ (51,811 )
Adjustments to reconcile net loss to net cash provided by operating activities:
               
 
Depreciation and amortization
    43,992       65,792  
 
Impairment of long-lived assets
    33,113       609  
 
Amortization of debt issuance costs
    774       374  
 
Non-cash content and distribution services
    12,149       13,409  
 
Non-cash stock-based compensation
    7,558       14,890  
 
Non-cash portion of restructuring and integration charge
          617  
 
Gain on investments
    (183 )     (5,866 )
 
Changes in operating assets and liabilities:
               
   
Accounts receivable
    (5,262 )     2,097  
   
Inventory
    (920 )     1,481  
   
Prepaid content and distribution services
    (445 )     (938 )
   
Accounts payable
    1,827       (5,108 )
   
Accrued expenses
    (26,885 )     1,210  
   
Deferred revenue
    478       10,871  
   
Other, net
    4,751       (1,116 )
 
   
     
 
     
Net cash provided by operating activities
    37,319       46,511  
 
Cash flows from investing activities:
               
Proceeds from maturities and sales of available-for-sale securities
    2,631       101,826  
Proceeds from maturities and redemptions of held-to-maturity securities
    102,919       1,055  
Purchases of available-for-sale securities
    (6,730 )     (201,565 )
Purchases of held-to-maturity securities
    (124,931 )     (246,072 )
Purchases of property and equipment
    (9,571 )     (14,370 )
Cash paid in business combinations, net of cash acquired
    (14,701 )     (2,924 )
 
   
     
 
     
Net cash used in investing activities
    (50,383 )     (362,050 )
 
Cash flows from financing activities:
               
Proceeds from issuance of common stock
    28,578       13,369  
Payments of notes payable and other
    (6,563 )     (4,021 )
Redemption of Series B Preferred Stock
          (10,000 )
Purchases of treasury stock
    (18,125 )     (88,747 )
Net proceeds from issuance of convertible debt
    290,500       292,000  
 
   
     
 
     
Net cash provided by financing activities
    294,390       202,601  
Effect of exchange rates on cash
    663       899  
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    281,989       (112,039 )
Cash and cash equivalents at beginning of period
    179,541       286,273  
 
   
     
 
Cash and cash equivalents at end of period
  $ 461,530     $ 174,234